|
|
|
|
|
|
|
|
|
Webinar Registrations: 142 Investors Registered: 54
On Thursday July 16th, 11 AM -12 PM Pacific Time, David Hess of Tress Capital will Moderate the first Investor Hot Seat where MyCureAll will be the first company to sit in the Hot Seat. Register now to be a part of the action!"
Moderator
Agenda
|
Free Registration for investors, sources of capital, industry professionals and companies raising capital.
Click Zoom Icon to Register
|
|
Requirements to be an Investor Judge
|
ModeratorDavid Hess
President
Tress Capital 
|
Investor Judges |
Company in the Investor Hot Seat - MyCureAll
|
MyCureAll, LLC
|
Elaine Richer, BSPharm, RPh
CEO & Founder
MyCureAll 
|
Jacques Nir, LCSW
COO & Founder
MyCureAll 
|
MyCureAll Information
|
Name of Company - MyCureAll, LLC
Year Started: 2019 Company website: www.mycureall.com Email: [email protected] Company Revenue: pre revenue Number of employees: 6 How much capital has been raised or founders invested in the company to date?: $300,000 Amount of Capital Raising: $2,000,000 What you offering investors: 7% Convertible Notes with up to three-year term, which Converts to MyCureAll equity at a 20% discount. |
MyCureAll Power Point
|
|
Elaine Richer, BSPharm, RPh, CEO & Founder, MyCureAll
Ms. Richer is a highly seasoned Pharmacist and healthcare professional that has held leadership roles in three Fortune 500 companies that include Rite Aid, Walgreens, and CVS Caremark. Ms. Richer is a graduate of Long Island University School of Pharmacy and has been a licensed pharmacist in New Jersey and Florida for over 20 years. Ms. Richer wants to make our society a better place, and her goal is to decrease opioid overdoses, decrease deaths from suicides and overdoses, reunite families suffering due to drug addiction, and help patients achieve the most effective pain control. Ms. Richer is dedicated to providing quality patient care and ensuring improved clinical outcomes. In her 20-plus years as a pharmacist, she has seen tens of thousands of patients for dozens of different conditions. As a pharmacist, she always strives to help patients, make their lives happier, healthier, and ease their burdens. Addiction is a tough illness and she feels honored to help patients on their road to recovery. At MyCureAll, her mission is to optimize innovation to treat pain properly, while preventing addiction at its core, and ensure improved clinical outcomes. She has successfully trained and managed diverse teams of pharmacists and has in-depth experience in all aspects of the Pharmacy benefit managers (PBM) industry that are companies that manage prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers, and other payers. |
|
Jacques Nir, COO & Founder, LCSW, MyCureAll
Mr. Nir has been the Director of Substance Abuse outpatient programs at the redesigned New York State OASAS (Office of Alcoholism and Substance Abuse Services) inpatient element treatment facilities for the past 12 years. Mr. Nir has provided quality care as a Licensed Clinical Social Worker (LCSW) for 24 years and been responsible for multi-million-dollar budgets with OASAS and the New York Office of Mental Health. Mr. Nir is a graduate of Columbia University School of Social Work and Adjunct Professor at Columbia University School of Social Work. The Office of Addiction Services and Supports (OASAS) oversees one of the nation’s largest addiction services systems with approximately 1,600 prevention, treatment and recovery programs. OASAS chemical dependence treatment programs have an average daily enrollment of nearly 100,000 people and serve approximately 234,000 individuals every year. This includes the direct operation of 12 Addiction Treatment Centers, which serve around 8,000 persons per year. OASAS is the single designated state agency responsible for the coordination of state-federal relations in the area of addiction services. Our mission is to improve the lives of New Yorkers by leading a comprehensive premier system of addiction services for prevention, treatment, and recovery. Mr. Nir has devoted his career to the public sector of social work and has worked with community-based programs for over 20 years. The evidence indicates and supports medicinal cannabis and CBD as a MAT (medication assisted treatment) protocol for both the OASAS (Office of Alcoholism and Substance Abuse Services) and OMH (Office of Mental Health). Our program will save lives, increase compliance with recovery, and reduce Medicaid expenditures. CBD and medicinal cannabis, administered with continuing care, will prevent relapse from opiates and promote psychiatric treatment. These substances need to be covered by an individual's insurance policy. As the data proves, we will save lives and provide a safer, alternative form of medical treatment to reduce recidivism and redundant services. |
